Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Brachytherapy|October 15, 2018
A prospective analysis of catheter complications for gynecological cancers treated with interstitial brachytherapy in the 3D eraLucas C Mendez, Pencilla Lang, Chirag Patel, et al.
Head & Neck|January 29, 2019
Prospective evaluation of pretreatment and intratreatment FDG PET-CT SUV stability in primary head and neck cancerLucas C Mendez, Tatiana Conrad, Justin Lee, et al.
Gynecologic Oncology|November 9, 2020
3D image-guided interstitial brachytherapy for primary vaginal cancer: A multi-institutional experienceChristopher D Goodman, Lucas C Mendez, Vikram Velker, et al.
Advances in Radiation Oncology|March 17, 2021
Risk of Chronic Opioid Use After Radiation for Head and Neck Cancer: A Systematic Review and Meta-AnalysisSondos Zayed, Cindy Lin, R Gabriel Boldt, et al.
Brachytherapy|November 16, 2017
Pattern of relapse and dose received by the recurrent intraprostatic nodule in low- to intermediate-risk prostate cancer treated with single fraction 19 Gy high-dose-rate brachytherapyLucas C Mendez, Ananth Ravi, Hans Chung, et al.
Scientific Reports|August 8, 2024
Three-dimensional trans-rectal and trans-abdominal ultrasound image fusion for the guidance of gynecologic brachytherapy procedures: a proof of concept studyTiana Trumpour, Carla du Toit, Alissa van Gaalen, et al.
Nature Reviews. Urology|August 14, 2021
Practical considerations for prostate hypofractionation in the developing worldMichael Yan, Andre G Gouveia, Fabio L Cury, et al.
Radiation Oncology (London, England)|April 8, 2020
Comparison of CTVHR and organs at risk contours between TRUS and MR images in IB cervical cancers: a proof of concept studyLucas C Mendez, Ananth Ravi, Kevin Martell, et al.
Chinese Clinical Oncology|September 6, 2024
Efficacy and safety of PARP inhibitors in the treatment of prostatic cancer: a systematic review and network meta-analysisYueting Huang, Hui He, Lufan Liang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 4, 2022
Radiotherapy-related toxicity for localized prostate cancer: meta-analysis comparing conventional or moderately hypofractionated vs. ultrahypofractionated protocolsWilly Baccaglini, Icaro T de Carvalho, Felipe P A Glina, et al.
Pageof 6